The research lab led by Dr. Colleen B. Jonsson at the University of Tennessee Health Science Center focuses on developing new drugs, vaccines, and diagnostics to combat infectious diseases and bioterrorism threats. Operating within a state-of-the-art biosafety level 3 (BSL-3) facility, the team works on enhancing biosafety practices and research support for medical countermeasures against emerging pathogens. The lab collaborates with various institutions and emphasizes training and management of biosafety practices in alignment with public health and safety standards.